A Preview Of Greenbrier Companies’s Earnings

Greenbrier Companies (NYSE:GBX) is set to give its latest quarterly earnings report on Monday, 2022-07-11. Here's what investors need to know before the announcement. Analysts estimate that Greenbrier Companies will report an earnings per share (EPS) of $0.59.

Greenbrier Companies (NYSE:GBX) is set to give its latest quarterly earnings report on Monday, 2022-07-11. Here’s what investors need to know before the announcement.

Analysts estimate that Greenbrier Companies will report an earnings per share (EPS) of $0.59.

Greenbrier Companies bulls will hope to hear the company to announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Past Earnings Performance

Last quarter the company beat EPS by $0.19, which was followed by a 2.7% drop in the share price the next day.

Here’s a look at Greenbrier Companies’s past performance and the resulting price change:

Quarter Q2 2022 Q1 2022 Q4 2021 Q3 2021
EPS Estimate 0.19 0.21 0.74 0.13
EPS Actual 0.38 0.32 0.98 0.69
Price Change % -2.7% -5.84% -4.58% 8.07%

eps graph

Stock Performance

Shares of Greenbrier Companies were trading at $34.06 as of July 07. Over the last 52-week period, shares are down 24.39%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.

To track all earnings releases for Greenbrier Companies visit their earnings calendar on our site.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Alnylam Announces Preliminary Q4 And FY23 Global Net Product Revenues And Provides Additional Updates; Q4 Net Product Revenues For ONPATTRO And AMVUTTRA ~$79M And $175M; Q4 Net Product Revenues For GIVLAARI And OXLUMO ~$59M And $33M

– Achieved Full Year 2023 Preliminary Global Net Product Revenues of $1,241 Million for ONPATTRO®, AMVUTTRA®, GIVLAARI®, and OXLUMO®, Representing 39% Annual Growth (39% Using Constant Exchange

ALNY